Osaic Holdings’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.35K Sell
10,495
-5
-0% -$2 ﹤0.01% 7148
2026
Q2
$5.78K Hold
10,500
– – ﹤0.01% 6859
2026
Q1
$27.5K Sell
10,500
-15,000
-59% -$35K ﹤0.01% 5642
2025
Q4
$37.5K Hold
25,500
– – ﹤0.01% 5437
2025
Q3
$24.6K Buy
25,500
+15,000
+143% +$12.2K ﹤0.01% 5796
2025
Q2
$6.83K Buy
10,500
+500
+5% +$360 ﹤0.01% 6371
2025
Q1
$6.1K Sell
10,000
-500
-5% -$435 ﹤0.01% 6073
2024
Q4
$11K Buy
10,500
+10,000
+2,000% +$17.3K ﹤0.01% 5727
2024
Q3
$980 Hold
500
– – ﹤0.01% 6847
2024
Q2
$1K Sell
500
-1,000
-67% -$1.72K ﹤0.01% 6815
2024
Q1
$2.07K Hold
1,500
– – ﹤0.01% 6455
2023
Q4
$1.7K Hold
1,500
– – ﹤0.01% 6587
2023
Q3
$2.26K Hold
1,500
– – ﹤0.01% 6586
2023
Q2
$2.4K Buy
+1,500
New +$1.28K ﹤0.01% 6598

Other funds holding CNTX

Osaic Holdings's CNTX Position: Q3 2026 in Review

Osaic Holdings reduced its Context Therapeutics (CNTX) stake by 0.05% in Q3 2026, selling an estimated $2 and leaving 10,495 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #7148.

Osaic Holdings first reported a position in CNTX in Q2 2023 and has held it in 14 quarters since. The position peaked at $37.5K in Q4 2025. 85 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • Osaic Holdings held 10,495 shares of Context Therapeutics worth $3.35K as of Q3 2026.
  • Osaic Holdings sold 5 Context Therapeutics shares in Q3 2026, an estimated $2.
  • Context Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7148 holding.
  • Osaic Holdings first reported a position in Context Therapeutics in Q2 2023 and has held it in 14 quarters since.
  • Osaic Holdings's Context Therapeutics position peaked at $37.5K in Q4 2025.
  • 85 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.